3rd European Lung Cancer Conference

3rd European Lung Cancer Conference

18 - 21 April, 2012
Geneva, Switzerland

  1. Advanced NSCLC
  2. Advanced NSCLC
  3. Biomarkers and impact on future clinical trials
  4. Brain and bone metastases management
  5. Delivering pathology for personalised medicine in lung cancer: What goes on inside the ‘Black Box’?
  6. Developments in targeted therapy
  7. Early stage and locally advanced NSCLC
  8. Early stage and locally advanced NSCLC
  9. Individualised treatment in early non-small cell lung cancer
  10. Individualized treatment of advanced NSCLC with available agents
  11. Keynote Lecture: Lung cancer screening
  12. Keynote Lecture: The evolution of molecular targeted treatment
  13. Localised therapy of metastatic disease to the lung
  14. Maintenance treatment in advanced NSCLC
  15. Mediastinal staging: EBUS, EUS, mediastinoscopy or what?
  16. Mesothelioma
  17. Mesothelioma revisited
  18. Metastases to and from the lung
  19. Oligometastatic NSCLC
  20. Pathology: Changes in morphological and molecular approaches
  21. PN2: The optimal treatment in 2012
  22. Prevention, Early detection, Prognosis, Epidemiology, Tobacco control
  23. Radiotherapy
  24. Screening and consequences
  25. Staging
  26. State-of the-art: Suggested treatment algorithms
  27. State-of-the-art staging
  28. Surgery
  29. Targeted therapies in NSCLC
  30. The epidemiology of lung cancer
  31. The spectrum of neuroendocrine lung tumors
  32. Thymoma
  33. TKI as first-line treatment of advanced NSCLC harbouring activating EGFR mutation
  34. Translational research, Biology and Pathology
  35. Translational research, biology and pathology I
  36. Translational research, biology and pathology II
  37. Unresolved issues

Search within Webcasts

 
 

 

 
 
 
 
 
 

Spotlight

How do we understand cancer’s genomic heterogeneity at different distant sites?

Session: Heterogeneity of breast cancer: How much is there at the start and how much happens over time

Congress: IMPAKT Breast Cancer Conference - 2013

02 - 04 May, 2013; Brussels, Belgium

Most Viewed Webcasts